Developing asthma in childhood from exposure to secondhand tobacco smoke: insights from a meta-regression*
Asma na infância por exposição ao tabagismo passivo: compreensão a partir de uma meta-regressão
Kathleen Vork; Rachel Broadwin; Robert Blaisdell
Air Toxicology and Epidemiology Branch, Office of Environmental Health Hazard Assessment, California Environmental Protection Agency. 1515 Clay St., 16th Floor, Oakland CA 94612 USA. firstname.lastname@example.org
Studies have shown links between household secondhand tobacco smoke (SHS) exposure and induction of childhood asthma. But the true nature of this link remains unclear in many studies. We conducted a meta-analysis of studies published from 1970 to 2005 to uncover consistent patterns of relative risk estimates (RRs), and found substantial heterogeneity within initial summary RRs of 1.48 [95% confidence interval (CI), 1.32-1.65], 1.25 (1.21-1.30), and 1.21 (1.08-1.36), for ever, current, and incident asthma, respectively. Lack of control for type of atopy history (familial or child) and child's own smoking status within studies and age category altered summary RRs in separate metaregressions. After adjustments, consistent patterns of association emerged between SHS exposure and childhood asthma induction. Our summary RR of 1.33 (95% CI, 1.14-1.56) from studies of incident asthma among older children (618 years old) is 1.27 times the estimate from studies of younger children and higher than estimates from earlier meta-analyses. This showns that exposure duration may be a more important factor than previously understood, and suggests that SHS could be a more fundamental cause of childhood asthma than some previous meta-analyses have indicated.
Key words: Childhood asthma, Environmental tobacco smoke, Meta-analysis, Meta-regression, Relative risk, Secondhand tobacco smoke
Diversos estudos demonstraram a ligação entre a exposição ao tabagismo passivo domiciliar (TPD) e a ocorrência de asma na infância. A verdadeira natureza desta ligação, no entanto, continua não esclarecida em muitos deles. Uma meta-análise de estudos publicados entre 1970 e 2005 conduzida a fim de revelar padrões consistentes de estimativas de risco relativas (RRs) revelou heterogeneidade substancial do RR sumário inicial de 1,48 [intervalo de confidência (IC) de 95% , 1,32-1,65], 1,25 (1,21-1,30), e 1,21 (1,08-1,36), e de 1,21 (1,08-1,36), para a asma intermitente e persistente, respectivamente. A falta de controles para tipos de história de atopia (familiar ou da criança) e sobre a condição de fumante da própria criança, assim como de faixas etárias, alterou os RRs em meta-regressões individuais. Após ajustes, emergiram padrões de associação consistentes entre exposição ao TPD e asma infantil. Nosso RR sumário de 1,33 (95% CI, 1,14-1,56) dos estudos de asma intermitente entre crianças maiores (entre 6 e 18 anos) é 1,27 vezes a estimativa de estudos feitos com crianças menores, além de ser maior do que as estimativas de meta-análises anteriores. Isto demonstra que a duração da exposição pode ser um fator mais importante do que se pensava, e sugere a exposição ao TPD como causa mais fundamental de asma na infância do que indicado em estudos anteriores.
Palavras-chave: Asma na infância, Tabagismo ambiental, Meta-análise, Meta-regressão, Risco relativo, Tabagismo passivo
Asthma in childhood becomes a lifelong condition for many people, and there is evidence that its prevalence has increased over the past 50 years1. Direct and indirect severe impacts on general health, well-being, and premature death can lead to large costs to the health care system for the management and treatment of asthma. The role of secondhand tobacco smoke (SHS) in asthma exacerbation is well accepted2, whereas its role in childhood asthma induction is less well understood. Several reviews and meta-analyses have weighed the evidence of a causal relationship between exposure to SHS and the onset of asthma in children2-6.
These reviews and meta-analyses differ in their conclusions about the sufficiency of evidence to infer a causal relationship between SHS exposure and asthma induction in children.
The U.S. EPA and California EPA concluded that SHS exposure is causally associated with an increase in the incidence of childhood asthma4,6, based on studies of young children. Strachan and Cook5 observed elevated estimates of relative risk (RRs) from studies of preschool age and equivocal RRs from studies of older children. Their metaanalysis, originally conducted in the mid-1990s, was updated in the most recent Surgeon General's Report (SGR) on Health Effects from Involuntary Exposure to Tobacco Smoke4. The SGR concluded that the evidence is suggestive, but not sufficient to infer a causal relationship between SHS and the induction of childhood asthma. The SGR's main reason for this conclusion is that the small number of studies that examined an association of SHS exposure from parental smoking with asthma incidence among older children (when there is reasonable diagnostic certainty) found inconsistent evidence of elevated RRs.
Many additional individual epidemiologic studies have been published since 2001 (the cutoff of Strachan and Cook's latest update in the SGR)7-14. Several of these newer studies have reported that control for important confounding variables such as atopy history (family or child history of atopy), prenatal exposure to maternal smoking, and smoking status of older children can substantially alter RRs7- 9, 12. Because atopy history was a particularly important confounder, we chose to conduct a meta-analysis of studies that controlled for atopy history. We examined the effects of other potentially confounding factors and study-wide characteristics on the summary RR of developing childhood asthma from exposure to household SHS to see whether consistent patterns of RRs emerge.
One of our goals was to use meta-regression on atopy-controlled studies to quantitatively explore the effects of these other potentially important sources of heterogeneity on the summary RR. Some of the heterogeneity among RRs reported in previous metaanalyses2, 3,5 may be related to uncontrolled confounding factors such as atopy history, age, sex, race, and the status of smoking in older study subjects. Other sources of heterogeneity among studies may include the age at which exposure and disease status are assessed, the assessment of maternal smoking versus other SHS sources, the evaluation of prenatal versus postnatal SHS exposure, the use of asthma incidence versus asthma prevalence as the outcome measure, the type of study design, or the subject recruitment source.
Our systematic review considered studies addressed in the meta-analyses of Cook and Strachan3, OEHHA4, Strachan and Cook5 and U.S. DHHS2. Our meta-analysis used the power provided by the more recent studies and the simultaneous examination of multiple characteristics through meta-regression to further examine the relationship between SHS exposure and induction of childhood asthma. We were particularly interested in the relationship between household SHS exposure and childhood asthma induction in older children.
We requested a literature search for SHS as a risk factor in the development of childhood asthma examined in epidemiologic studies published between 1970 and 2005. Outcome key words included asthma, wheezy bronchitis, asthmatic bronchitis, and reactive airway disease. Exposure key words included ETS, environmental tobacco smoke, passive smoking, secondhand smoke, involuntary smoke, tobacco smoke pollution, and cigarette smoke. We limited the search to asthma in childhood and adolescence (through 18 years of age).
A professional experienced librarian searched PubMed (http://www.pubmed.gov), Web of Science (http://portal.isiknowledge.com/), Biosis Previews(http://portal.isiknowlege.com/), Toxline (http://toxnet.nlm.nih.gov), Scifinder Scholar (http://www.cas.org/products/sfacad/index.html), Environmental Sciences and Pollution Management (http://www.csa.com), Melvyl (http://melvyl.cdlib.org), WorldCat (OCLC) Firstsearch (http://firstsearch.oclc.org), University of California and San Francisco Tobacco Control Archives (http://www.library.ucsf.edu/tobacco/). Manual searches were conducted from review articles and previous meta-analyses. When necessary, we contacted authors for additional information or for translations from languages other than English.
We developed eight criteria to select studies from among peer reviewed articles. First, studies should present a) outcomes of the development (not exacerbation) of new cases of asthma or, because of ambiguities related to the diagnosis of asthma in young children, wheezy bronchitis (but not wheeze alone); we used broad criteria to define new incident cases of asthma that included both allergic and nonallergic descriptions of asthma. However, we sought to include all studies that identified cases of asthma in their analyses by other criteria than symptoms of wheeze alone. Our definition included asthma, wheezy bronchitis, or asthma/wheeze that was ever or currently recognized by doctor diagnosis or by a set of symptoms that are recognized criteria for diagnosing asthma in addition to wheezing.
We also included asthma identified through parental response to pilot-tested or standardized questionnaires on respiratory health. Studies should also present b) comparable groups of subjects (i.e., exposed and unexposed, cases and referents selected by the same criteria); c) at least one source of postnatal household SHS exposure; d) adequate data for extracting or calculating RRs and their standard errors; this information may be presented as odds or rate ratios or estimates of relative risk; e) results for children (018 years of age) where the child was the unit of analysis; f ) completed and original work (not abstracts of work in progress or reviews); g) reports written in languages other than English that are commonly spoken in Europe (i.e., German, Italian, French, and Spanish); and h) studies that controlled for the confounding effect of atopy history because atopy has such a strong association with asthma and parental smoking behavior. Our control for atopy history category included: family history of allergy or asthma; childhood diagnosis of allergic conditions other than asthma, such as eczema, hay fever, or allergic rhinitis; the respondent in the study reported symptoms of allergic conditions; or the study investigator stratified on an indicator of atopy such as skin-prick test results. We considered the study controlled for atopy history if the study restricted the selection of subjects to children with, subgroups were stratified by, or the estimate of RR was statistically adjusted for atopy history as defined above. We rejected studies that did not meet these criteria. When more than one analysis was conducted on the same set of children, we included information from multiple articles if they provided unique information about the children.
We extracted RRs and standard error estimates from publications using methods described by Greenland15. Odds ratios were corrected to RRs even though the prevalence of asthma was often not much more than 10% in the study population16. We initially analyzed studies from which population prevalence estimates were not available (i.e., from many case-control studies), and later removed them from the pool of available studies.
The variables we considered as potential covariates in each meta-regression are described in Table 1. We grouped covariates into two subgroups and gave each covariate a value of 0 or 1. We considered that a study controlled for a covariable if the study restricted the selection of subjects to children from a single covariable category, or if the subgroups were stratified by, or the estimate of RR was statistically adjusted to, persons who belong to a single category of that covariable. We classified SHS exposure as average (or adjusted to 15 cigarettes/day smoked in the home).
The first two meta-analyses in this review are an analysis of average SHS exposure on RRs from studies of newly diagnosed or persistent asthma (current asthma), and the RR from studies of asthma that may have occurred early in life and subsequently resolved (ever asthma). In the third meta-analysis of SHS effect on asthma incidence in this review, we included studies that examined SHS exposure effects and classified subjects by continued exposure before the onset of asthma.
Where possible, we collapsed exposure levels within studies that used a common reference group and adjusted for correlations among estimates using methods described by Greenland and Longnecker17. We adjusted exposure measures such as cotinine levels in blood and the number of smokers in the home or cigarettes smoked by household occupants to be approximately equivalent to the number of cigarettes smoked per day in the home [see Supplemental Material, Appendix A for the details and conversion factors used for this adjustment (http://www.ehponline.org/docs/2007/10155/suppl.pdf)].
Although most of the RRs in the studies included in this review indicated a positive association for both current and ever asthma, there was substantial heterogeneity in the magnitude of the SHS effect across studies. We performed separate subanalyses for studies Secondhand tobacco smoke and new childhood asthma of current and ever asthma because we suspected that differences in study design and case detection specific to the type of asthma studied might explain RR heterogeneity. Within cohort studies that classified subjects by exposure status at the start of follow-up, we sought to examine the effect of exposure years on incident asthma. Each analysis is comprised of independent sets of study subjects. Several studies provided separate estimates of RR for both current and ever asthma. To avoid overlapping populations among analyses, we included only the current asthma RR.
We estimated summary RRs using inverse variance-weighted least-squares methods18. If the chi-squared statistic from the homogeneity test was greater than its degrees of freedom, we used a random-effects method to account for between-study variability; otherwise, we used a fixed-effects method.
To explore the sources of RR heterogeneity, we modeled the log RR as a function of predictors in a linear meta-regression model. Each covariate was considered as a potential modifier of the RR. We included all covariates for which the p-value was < 0.1.
We regarded the model as accounting for RR heterogeneity if the homogeneity chisquare was less than or equal to its degrees of freedom. If our model did not account for the heterogeneity in this sense, after considering all eligible covariates, we examined the influence of individual studies. We detected outliers by removing one study at a time and estimating a weighted average estimate of all other studies. We conducted this study influence analysis using "Metainf," a statistical function of Stata version 8.0 (StataCorp. LP, College Station, TX) that sequentially removes one study at time, and then recalculated RR to determine the effect that the removed study's RR has on the average RR for all studies.
We managed data using SAS version 8.2 (SAS Institute Inc., Cary, NC) and Microsoft Office Excel 2000 ( Microsoft, Redmond, WA) and analyzed the data using Stata (version 8.0).
Our search generated > 500 abstracts for review, which produced 300 potentially relevant articles. We received responses from six of the eight authors we had contacted to obtain additional information needed to determine a study's eligibility. Thirty-eight articles reported at least one risk estimate that met our inclusion criteria (Tables 2-4). Twelve articles19-30 and the Abacci Atlas website31 provided information on additional characteristic about the study design or population associated with 10 of these studies. We rejected 248 articles; in cases where there were multiple reasons for exclusion, we have reported only one (see Figure 1 for details).
Study methodologies and key characteristics
Tables 2-4 describe the 53 studies meeting the eight criteria that we have included in our meta-analyses. These studies include approximately 200,000 children and adolescents (<18 years of age) from 20 countries.
About half of the studies that examined average household SHS exposure and current asthma were casecontrol and half were cross-sectional design. Studies ranged from < 200 to > 100,000 study subjects. All but one of the studies that examined average household SHS exposure and ever asthma were cross-sectional. Among the cohort studies, populations ranged from < 200 to nearly 15,000 subjects.
Summary RR using different exposure reference groups
The summary or weighted average of RRs, tests for RR heterogeneity, and RR percentiles are shown in Table 5 for each meta-regression. Before combining estimates of RR, we applied a correction factor to odds ratios and removed five studies (four current asthma, one ever asthma) that did not provide an estimate of prevalence. Among studies of current asthma, a homogeneous (p = 0.528) combined estimate of RR emerged. The observations we included in our corrected analyses are included in online tables (Supplemental Material, available online at http://www.ehponline.org/docs/2007/10155/suppl.pdf). Substantial heterogeneity among cross-sectional studies was observed in the ever asthma group when the reference group was no household exposure, and among the incident asthma group when the reference group was no maternal smoking exposure. Results are presented from random-effects models.
RRs tended to be similar in eight cohort studies for which the SHS exposure was assessed before the onset of asthma [summary RR = 1.21; 95% confidence interval (CI), 1.08-1.36; RR range, 0.84-1.49] to 11 casecontrol studies or crosssectional studies of average household SHS exposure and current asthma where exposure to SHS was assessed at the time of diagnosis or case identification (summary RR = 1.25; 95% CI, 1.21-1.30; RR range, 0.86-2.17).
The summary RRs among prevalence studies was higher among 23 studies of ever asthma, at 1.48 (95% CI, 1.32-1.65; RR range, 0.57-5.81) (Table 5).
Household SHS exposure and ever asthma
The observations we included in our subgroup analyses of average household SHS exposure and ever asthma are summarized in Table S1 (Supplemental Material, available online at http://www.ehponline.org/docs/2007/10155/suppl.pdf). Substantial heterogeneity remained (homogeneity p < 0.001) after fitting a metaregression model that included four covariates and for which no additional covariates entered the model. Most of this heterogeneity appeared to be attributed to the summary estimate from one large study14. We treated this study as an outlier because it used a stricter definition of asthma to classify subjects as cases compared with the other studies included in our database. Classifying subjects in this way might have resulted in a bias downward if milder cases of asthma among children exposed to SHS were classified as noncases. After removing this outlier study, three covariates then accounted for heterogeneity in the meta-regression model: studies that were not a) controlled for family history of atopy, b) restricted to nonsmoking children, c) restricted to children of school age (Table 6).
The strongest modifier of the ever asthma summary RR was lack of control for a child's own smoking habits. The study summary RRs from studies that did not control for this covariate were 1.35 times higher than controlled studies. Lack of control for a) family history of atopy, b) age category of the study subjects, and c) smoking habits among study subjects were weaker modifiers for ever asthma studies [summary RRs were 0.84 and 1.20 times the joint reference estimate of RR of 1.21 (95% CI, 1.17-1.26); see Table 6 for reference categories]. This estimate is lower than the corresponding summary RR without adjustment for covariates, 1.48 (95% CI, 1.32-1.65; Table 5).
Household SHS exposure and incident asthma
The observations we included in our subgroup analyses of household SHS exposure and incident asthma are summarized in online Table S2 (Supplemental Material, available online at http://www.ehponline.org/docs/2007/10155/suppl.pdf).
The results of the meta-regression for eight cohort studies appear at the end of Table 6. SHS exposure and incident asthma RR was 0.79 times higher among studies of preschool children than among studies of school-age children, and 0.82 times higher when studies did not control for child atopy than for studies that controlled for this covariable.
The predicted RR for SHS exposure effect on incident asthma among children in the joint reference category of all covariates was 1.33 (95% CI, 1.14-1.56; see Table 6 for reference categories). This estimate is higher than the corresponding summary RR without adjustment for covariates, 1.21, (95% CI, 1.08-1.36; Table 5).
This meta-analysis extends previous work by focusing on atopy-controlled studies, which has been well established as a source of confounding in individual studies, and examining the relationship between SHS exposure and onset of childhood asthma. We have evaluated and adjusted for additional sources of heterogeneity among summary RR by meta-regression methods and observed consistent patterns of elevated RRs among studies. We observed a consistent, positive association between household SHS exposure and current, ever, and incident asthma. We also observed an elevated summary RR for incident asthma that was statistically significant among studies of schoolchildren with postnatal exposure to SHS. We did not find that restricting exposure to postnatal SHS was an important modifier of summary RRs for any of the asthma outcomes. Recent reports by Cook and Strachan3 and the U.S. DHHS2 have concluded that prenatal exposure to maternal smoking is not necessary to elicit an adverse effect. Our meta-regressions support this conclusion.
In our meta-regression of average household SHS exposure and ever asthma, covariate control accounted for much of the heterogeneity. The effect of not controlling for family history of atopy reduced the RR among ever asthma studies, and lack of control for both child and family history of atopy reduced the estimate of RR among incident asthma studies. These findings suggest that this confounding variable biases the estimate of RR toward the null.
Recent studies have identified elevated levels of endotoxin in cigarette smoke and SHS indoor spaces63, 64. It is plausible that elevated endotoxin exposure would cause elevated immunoglobulin E levels in families (including the child) exposed to SHS, and thus affect the likelihood of atopy and subsequent asthma. However, we were unable to analyze the relationship between exposed and unexposed family members and their atopy (and subsequent asthma) status separately because we did not have individual-level data.
We observed that summary RRs from studies that examined ever asthma among younger children were slightly higher than RRs from studies of exclusively older children.
These findings are contrary to the findings from cohort studies but consistent with previous reviews3, 5.
Most of the cross-sectional studies assessed SHS exposure status by asking if household or parental sources currently smoked. One explanation of these findings is that RRs from cross-sectional studies of older children could be biased downward because assessment of current SHS exposure status may not reflect early-life exposure. For example, parental smoking habits may change once symptoms of allergy or asthma appear in their children. If this occurred among older asthmatics, then these children may be classified as nonexposed, which would result in a differential misclassification of exposure among cases. This source of bias is avoided in prospective cohort study designs.
When studies did not restrict subjects to nonsmoking children, summary RRs were higher, possibly due to bias upward from exposure among studies that overlooked this source of SHS exposure. It is also possible that study subjects who themselves are smokers are more likely to have been exposed to higher levels of household SHS65.
Therefore, including smokers in the analysis would increase the RR of developing asthma among the study population. However, most studies did not assess whether asthma developed among study subjects before taking up a smoking habit of their own.
The RR for the average household SHS exposure effect on ever asthma appeared similar to the effect on current and incident asthma, according to our meta-regression analysis. The RR for prevalent asthma could be slightly lower because of bias downward if household exposure to SHS occurred up to the time of asthma diagnosis and then stopped. This would mean that asthmatics with past but not current household SHS might be misclassified as nonexposed.
Cook and Strachan3, Strachan and Cook5, and the U.S. DHHS2 observed a stronger RR for incident asthma or wheezing illness among younger children compared with their findings among older children. These investigators suggested that the stronger relationship with younger children might be attributed to exacerbation of intercurrent infection among young children, resulting in transient wheeze that would tend to diminish with age and increasing airway caliber. This proposed mechanism would suggest that SHS may not be a sole primary cause of early childhood asthma; rather, it may be one of several required co-factors that when combined may lead to asthma development.
In our cohort study meta-regression, we also found that much of the observed heterogeneity was accounted for by the age category of children in the study. Most important, older children exposed to SHS were more likely than younger children to develop asthma. We found no evidence that RRs from studies using physician diagnosis to identify cases were systematically different than RRs from studies that did not identify cases in this way. The differences in our meta-analysis findings versus earlier studies are likely attributed to differences in approach and the inclusion of studies in our meta-analysis published after the previous meta-analyses. We looked more precisely at the relationship between SHS exposure and asthma as distinct from wheeze alone, and we restricted our analysis to studies that controlled for atopy history. Thus our metaanalysis examines a subtly different question than earlier meta-analyses3,5, and takes advantage of the increased body of epidemiologic literature.
Because cohort studies classify subjects by exposure at the start of follow-up, it is less likely that exposure misclassification would occur and more likely that the child's age is a reasonable surrogate measure of the length of time study subjects are exposed to household SHS. This positive relationship between a surrogate of duration of household SHS exposure and RR was also observed within individual studies57,42. Hence, a finding that higher summary RRs occurred in studies of older children suggests that SHS exposure duration may also play a fundamental role in the development of asthma.
The positive relationship with age category identified in these studies suggests that the risk of developing asthma from a longer time of exposure to SHS increases in later childhood. The RRs among studies that examined incident asthma were more positively associated with SHS exposure than were studies of prevalent asthma. The elevated RRs for the association between household SHS and prevalent as well as incident asthma suggest that the association between SHS exposure and asthma is not caused by selection or misclassification biases.
A mechanistic theory consistent with our findings holds that the development of asthma can be causally associated with the chronic effects from exposure to SHS on bronchial hyperreactivity rather than the acute effects of SHS exposure on airway caliber6, 66. Others have also recently drawn this conclusion ["postnatal exposure shows a causal link with the development of asthma in childhood"67; and "strong evidence also supports a causal role of environmental tobacco smoke in childhood asthma, especially in the induction of asthma, but also in the poor overall control of an established disease"68]. The question of asthma incidence increasing with age and duration of exposure is important because if RR increases with age and duration of exposure, it becomes less likely that asthma from SHS exposure early in life is attributed solely to a transient vulnerability in early childhood that is less likely to result in enduring disease. It also means that public health interventions to stop childhood SHS exposure may have a positive benefit in preventing asthma induction beyond early childhood.
Clearer understanding of the role of SHS in childhood asthma induction can help inform public health interventions to prevent childhood SHS exposure and the benefits from such interventions. Our analysis attempted to address some of the remaining concerns posed by previous reviewers who stated that the evidence for an association between household SHS exposure and new-onset asthma is equivocal especially among older children. We observed a positive and consistent pattern of association between household SHS exposure and the RR of developing asthma during childhood in our meta-analyses. In contrast to earlier findings, this association was not limited to younger children, certain high-risk populations, or prevalent cases. Similar to previous analyses, we did not find that prenatal exposure to SHS was necessary to observe elevated summary RRs for any of the asthma outcomes.
1. Ross Anderson H, Gupta R, Strachan DP, Limb ES. Fifty years of asthma: UK trends from 1955 to 2004. Thorax 2007; 62(1):85-90.
2. U.S. DHHS. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2006.
3. Cook DG, Strachan DP. Health effects of passive smoking-10: summary of effects of parental smoking on the respiratory health of children and implications for research. Thorax 1999; 54(4):357-366.
4. OEHHA. Health Effects of Exposure to Environmental Tobacco Smoke. Oakland, CA:Office of Environmental Health Hazard Assessment, California Environmental Protection Agency; 1997.
5. Strachan DP, Cook DG. Parental smoking and childhood asthma: longitudinal and case-control studies. Thorax 1998; 53(3):204-212.
6. U.S. EPA. Respiratory Health Effects of Passive Smoking: Lung Cancer and Other Disorders. EPA/600/6-90/006F. Washington, DC:Office of Research and Development, U.S. Environmental Protection Agency; 1992.
7. Gilliland FD, Li YF, Peters JM. Effects of maternal smoking during pregnancy and environmental tobacco smoke on asthma and wheezing in children. Am J Respir Crit Care Med 2001; 163(2):429-436.
8. Hessel PA, Klaver J, Michaelchuk D, McGhan S, Carson MM, Melvin D. The epidemiology of childhood asthma in Red Deer and Medicine Hat, Alberta. Can Respir J 2001; 8(3):139-146.
9. Jaakkola JJ, Nafstad P, Magnus P. Environmental tobacco smoke, parental atopy, and childhood asthma. Environ Health Perspect 2001; 109:579-582.
10. Kivity S, Sade K, Abu-Arisha F, Lerman Y, Kivity S. Epidemiology of bronchial asthma and chronic rhinitis in schoolchildren of different ethnic origins from two neighboring towns in Israel. Pediatr Pulmonol 2001; 32(3):217-221.
11. Mannino DM, Moorman JE, Kingsley B, Rose D, Repace J. Health effects related to environmental tobacco smoke exposure in children in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Pediatr Adolesc Med 2001; 155(1):36-41.
12. Pokharel PK, Kabra SK, Kapoor SK, Pandey RM. Risk factors associated with bronchial asthma in school going children of rural Haryana. Indian J Pediatr 2001; 68(2):103-106.
13. Sturm JJ, Yeatts K, Loomis D. Effects of tobacco smoke exposure on asthma prevalence and medical care use in North Carolina middle school children. Am J Public Health 2004; 94(2):308-313.
14. Takemura Y, Sakurai Y, Honjo S, Kusakari A, Hara T, Gibo M, Tokimatsu A, Kugai N. Relation between breastfeeding and the prevalence of asthma. Am J Epidemiol 2001; 154:115-119.
15. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987; 9:1-30.
16. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998; 280(19):1690-1691.
17. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992; 135(11):1301-1309.
18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188.
19. Aberg N, Hesselmar B, Aberg B, Eriksson B. Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991. Clin Exp Allergy 1995; 25:815-819.
20. Aberkane T. Air Quality Monitoring Report 1997. Report U98(43). [accessed 18 May 2007]. Available from: http://www.ecan.govt.nz/Plans+and+Reports/Air/Annual+Monitoring+Report/ zAQMonRpt97.htm
21. Al-Frayh A, Bener A, Al-Jawadi TQ. Prevalence of asthma among Saudi schoolchildren. Saudi Med J 1992; 13(6):521-524.
22. Bener A, Al-Jawadi TQ, Ozkaragoz F, Al-Frayh A, Gomes J. Bronchial asthma and wheeze in a desert country. Indian J Pediatr 1993; 60:791-797.
23. Bener A, Al-Jawadi TQ, Ozkaragoz F, Anderson JAD. Prevalence of asthma and wheeze in two different climatic areas of Saudi Arabia. Indian J Chest Dis Allied Sci 1993; 35(1):9-15.
24. Bergmann RL, Edenharter G, Bergmann KE, Forster J, Bauer CP, Wahn V, Zepp F, Wahn U. Atopic dermatitis in early infancy predicts allergic airway disease at 5 years. Clin Exp Allergy 1998; 28:965-970.
25. Franklin CA, Burnett RT, Paolini RJ, Raizenne ME. Health risks from acid rain: a Canadian perspective. Environ Health Perspect 1985; 63:155-168.
26. Luttmann H, Gromping U, Kreienbrock L, Treiber-Klotzer C, Wichmann HE. Cohort study on respiratory diseases and lung function in schoolchildren in southwest Germany-Part 1: Study design, prevalence and incidence of respiratory diseases. Zbl Hyg 1993; 194:525-539.
27. Moussa MA, Skaik MB, Yaghy OY, Salwanes SB, Bin-Othman SA. Factors associated with asthma in school children. Eur J Epidemiol 1996; 12(6):583-588.
28. MRC (Medical Research Council). Committee on Research into Chronic Bronchitis Questionnaire on Respiratory Symptoms. London: Publications Group, Medical Research Council; 1966.
29. MRC (Medical Research Council). Committee on Environmental and Occupational, Health, Respiratory Symptoms. London: Publications Group, Medical Research Council; 1986.
30. Ronmark E, Jonsson E, Platts-Mills T, Lundback B. Different pattern of risk factors for atopic and nonatopic asthma among children-report from the Obstructive Lung Disease in Northern Sweden Study. Allergy 1999; 54(9):926-935.
31. Shank P. Abacci Atlas: Demographics of the United Kingdom of Great Britain and Northern Ireland. 2000. [accessed 30 October 2003]. Available from: http://www.abacci.com/atlas/demography.asp? countryID=352
32. Agabiti N, Mallone S, Forastiere F, Corbo GM, Ferro S, Renzoni E, Sestini P, Rusconi F, Ciccone G, Viegi G, Chellini E, Piffer S. The impact of parental smoking on asthma and wheezing. SIDRIA Collaborative Group. Studi Italiani sui Disturbi Respiratori nell'Infanzia e l'Ambiente. Epidemiology 1999; 10(6):692-698.
33. Azizi BH, Zulkifli HI, Kasim S. Indoor air pollution and asthma in hospitalized children in a tropical environment. J Asthma 1995; 32(6):413-418.
34. Chen Y, Rennie DC, Dosman JA. Influence of environmental tobacco smoke on asthma in nonallergic and allergic children. Epidemiology 1996; 7(5):536-539.
35. Daigler GE, Markello SJ, Cummings KM. The effect of indoor air pollutants on otitis media and asthma in children. Laryngoscope 1991; 101(3):293-296.
36. Ehrlich RI, Du Toit D, Jordaan E, Zwarenstein M, Potter P,Volmink JA, Weinberg E. Risk factors for childhood asthma and wheezing. Importance of maternal and household smoking. Am J Respir Crit Care Med 1996; 154(3 Pt 1):681-688.
37. Murray AB, Morrison BJ. It is children with atopic dermatitis who develop asthma more frequently if the mother smokes. J Allergy Clin Immunol 1990; 86(5):732-739.
38. Palmieri M, Londobardi G, Napolitano G, Simonetti DML. Parental smoking and asthma in childhood. Eur J Pediatr 1990; 149(10):738-740.
39. Ronmark E, Lundback B, Jonsson E, Platts-Mills T. Asthma, type-1 allergy and related conditions in 7- and 8-year-old children in northern Sweden: prevalence rates and risk factor pattern. Respir Med 1998; 92(2):316-324.
40. Selcuk ZT, Caglar T, Enunlu T, Topal T. The prevalence of allergic disease in primary school children in Edirne, Turkey. Clin Exp Allergy 1997; 27(3):262-269.
41. Soto-Quiros M, Bustamante M, Gutierrez I, Hanson LA, Strannegard IL, Karlberg J. The prevalence of childhood asthma in Costa Rica. Clin Exp Allergy 1994; 24:1130-1136.
42. Wolf-Ostermann K, Luttmann H, Treiber-Klotzer C, Kreienbrock L, Wichmann HE. Cohort study on respiratory disease and lung function in schoolchildren in southwest Germany. Part 3: Influence of smoking and passivesmoking. Zbl Hyg 1995; 197:459-488.
43. Azizi BHO, Henry RL. The effects of indoor environmental factors on respiratory illness in primary school children in Kuala Lumpur. Int J Epidemiol 1991; 20(1):144-150.
44. Bener A, Facharzt ARAF, Al-Jawadi TQ. Parental smoking and the risk of childhood asthma. J Asthma 1991; 28(4):281-286.
45. Burchfiel CM, Higgins MW, Keller JB, Howatt WF, Butler WJ, Higgins IT. Passive smoking in childhood. Respiratory conditions and pulmonary function in Tecumseh, Michigan. Am Rev Respir Dis 1986; 133(6):966-973.
46. Gergen PJ, Fowler JA, Maurer KR, Davis WW, Overpeck MD. The burden of environmental tobacco smoke exposure on the respiratory health of children 2 months through 5 years of age in the United States: Third National Health and Nutrition Examination Survey, 1988 to 1994. Pediatrics 1998; 101(2):E8.
47. Goren AI, Hellman S. Passive smoking among schoolchildren in Israel. Environ Health Perspect 1991; 96:203-211.
48. Gortmaker SL, Walker DK, Jacobs FH, Ruch-Ross H. Parental smoking and the risk of childhood asthma. Am J Public Health 1982; 72(6):574-579.
49. Hajnal BL, Braun-Fahrlander C, Grize L, Gassner M, Varonier HS, Vuille JC, Wuthrich B, Sennhauser FH. Effect of environmental tobacco smoke exposure on respiratory symptoms in children. SCARPOL Team. Swiss study on childhood allergy and respiratory symptoms with respect to air pollution, climate and pollen. Schweiz Med Wochenschr 1999; 129(19):723-730.
50. Jenkins MA, Hopper JL, Flander LB, Carlin JB, Giles GG. The associations between childhood asthma and atopy, and parental asthma, hay fever and smoking. Pediatr Perinat Epidemiol 1993; 7(1):67-76.
51. Kay J, Mortimer MJ, Jaron AG. Do both paternal and maternal smoking influence the prevalence of childhood asthma? A study into the prevalence of asthma in children and the effects of parental smoking. J Asthma 1995; 32(1):47-55.
52. Le Roux P, Bourderont D, Loisel I, Collet A, Boulloche J, Briquet MT, Le Luyer B. Prevalence of asthma in the Havre area. Arch Pediatr 1995; 2(7):643-649.
53. Maier WC, Arrighi HM, Morray B, Llewellyn C, Redding GJ. Indoor risk factors for asthma and wheezing among Seattle school children. Environ Health Perspect 1997; 105:208-214.
54. Rasanen M, Kaprio J, Laitinen T, Winter T, Koskenvuo M, Laitinen LA. Perinatal risk factors for asthma in Finnish adolescent twins. Thorax 2000; 55:25-31.
55. Soyseth V, Kongerud J, Boe J. Postnatal maternal smoking increases the prevalence of asthma but not of bronchial hyperresponsiveness or atopy in their children. Chest 1995; 107(2):389-394.
56. Bergmann RL, Edenharter G, Bergmann KE, Lau S, Wahn U, the Multicenter Allergy Study Research G. Socioeconomic status is a risk factor for allergy in parents but not in their children. Clin Exp Allergy 2000; 30:1740-1745.
57. Neuspiel DR, Rush D, Butler NR, Golding J, Bijur PE, Kurzon M. Parental smoking and post-infancy wheezing in children: a prospective cohort study. Am J Public Health 1989; 79(2):168-171.
58. Ponsonby AL, Couper D, Dwyer T, Carmichael A, Kemp A, Cochrane J. The relation between infant indoor environment and subsequent asthma. Epidemiology 2000; 11(2):128-135.
59. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, Bjorksten B. Asthma and immunoglobulin e antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995; 95(4):500-505.
60. Strachan DP, Butland BK, Anderson HR. Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort. BMJ 1996; 312(7040):1195-1199.
61. Withers NJ, Low L, Holgate ST, Clough JB. The natural history of respiratory symptoms in a cohort of adolescents. Am J Respir Crit Care Med 1998; 158(2):352-357.
62. Zeiger RS, Heller S. The development and prediction of atopy in high-risk children: follow- up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. J Allergy Clin Immunol 1995; 95(6):1179-1190.
63. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999; 115(3):829-835.
64. Larsson L, Szponar B, Pehrson C. Tobacco smoking increases dramatically air concentrations of endotoxin. Indoor Air 2004; 14(6):421-424.
65. Wang TN, Ko YC, Chao YY, Huang CC, Lin RS. Association between indoor and outdoor air pollution and adolescent asthma from 1995 to 1996 in Taiwan. Environ Res 1999; 81(3):239-247.
66. Halken S, Host A, Nilsson L, Taudorf E. Passive smoking as a risk factor for development of obstructive respiratory disease and allergic sensitization. Allergy 1995; 50:97-105.
67. Gilmour MI, Jaakkola MS, London SJ, Nel AE, Rogers CA. How exposure to environmental tobacco smoke, outdoor air pollutants, and increased pollen burdens influences the incidence of asthma. Environ Health Perspect 2006; 114:627-633.
68. Jaakkola MS, Jaakkola JJ. Effects of environmental tobacco smoke on the respiratory health of adults. Scand J Work Environ Health 2002; 28(Suppl 2):52-70.
Article received 8 February 2007
Article accepted 28 June 2007
* This article was originally published by Environmental Health Perspectives 115:13941400 (2007). doi:10.1289/ehp.10155 available via http://dx.doi.org/ [Online 28 June 2007] and is part of the scientific collaboaration between Cien Saude Colet and EHP. The authors gratefully acknowledge S. Kheradpir, who provided important technical support, and M. Lipsett and C. Steinmaus for their helpful comments on early drafts of this manuscript. The authors declare they have no competing financial interests. Supplemental Material is available online at http://www.ehponline.org/docs/2007/10155/suppl.pdf